All Posts

Keep Saturday 5 September free. This year's online Update Day from the Goodfellow Unit brings you 13 experts to discuss what's been happening in paediatrics, prescribing, mental health, and so much more.The 2026 Primary Care Update webinar day includes: A day of practice-changing New Zealand-specific updates. 6 CPD hours (RNZCGP) and 6 professional development hours endorsed by the College of Nurses Aotearoa (NZ). Ongoing access to online archives of the recordings. This full

Issue 344 - 11 June 2026 Welcome to the fortnightly Health Improvement and Innovation Digest. The Digest has links to key evidence of interest, with access to new content arranged by topic. You can forward this newsletter to others who may be interested in receiving it. They can register and subscribe here. You can also access other recent issues of the digest here. If you have any queries, please email us at library@health.govt.nz Article Access For articles that aren't open

For this issue, I decided to do something a bit different and review some of the most impactful papers in diabetes and obesity research over the last 10 years. I have tried to encompass a broad range of areas where I feel the evidence has cemented or changed our understanding or management. As usual we have attached the PDF, and you can also view the issue online. Some of the highlights include: Teplizumab in relatives at risk for type 1 diabetes Outcomes in offspring a

This Review will feature key medical articles from global journals, and will cover topics such as hyperbaric chamber wound healing, bed sores, pressure ulcers, diabetic foot ulcers, negative pressure wound therapy, wound debridement, chronic wound care management and bacterial infection. As usual we have attached the PDF, and you can also view the issue online. Some of the highlights in this issue include: Negative pressure wound therapy plus alginate dressings Knowled

We have a potential opportunity for a male Nurse Practitioner to join our warm and friendly dedicated primary healthcare team at MeNZ Medical. If you are passionate about Men’s Health and can help provide skilled holistic care to our patients, please email office@menzmedical.com to express your interest. Our services include; full 'head-to-toe' medicals, minor surgical procedures including vasectomies, sexual health consultations (including PE/ED), sensitive male health care

He whakamārama mō Tui Ora - About us We do health differently at Tui Ora. As a holistic kaupapa Māori (Māori approach) primary care organisation which has been serving the Taranaki community for more than 25 years, we provide a wide range of health and social wellbeing services for our whānau (families). We follow a proven Māori model of care that puts whānau at the centre, empowering them to set their own life goals and create a pathway to reaching them. Our experienced and.

Henderson, West Auckland | 0.8–1.0 FTE Practice with purpose. Lead change. Make a genuine difference for whānau WaiHealth is a growing kaupapa Māori primary healthcare service based in West Auckland, dedicated to delivering equitable, whānau-centred care that improves health outcomes for our community. We are seeking an experienced and passionate Nurse Practitioner to join our supportive and collaborative clinical team. This is an opportunity to work to your full Nurse Practi

Kia ora koutou As Acting Director-General of Health while Audrey Sonerson is away, I want to take this opportunity to update you on a number of areas of focus for the Ministry. At the heart of this work is a shared goal - supporting New Zealanders to live longer, healthier lives. Ruth IssacActing Director-General of Health Budget 2026 The Vote Health package announced in Budget 2026 last week provides more than: $5.8 billion in new operating funding across the forecast perio

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. KIKUYA Spring THC20 CBD≤1% has been verified as meeting the minimum quality standar

Kia ora The June 2026 edition of Prescriber Update is now available on the Medsafe website. Please can you share it with your networks. Kind regards Medsafe Pharmacovigilance Team

Our latest CPD options for you: Chronic kidney disease, hyperuricaemia and gout - when to treat? WEBINAR 9 June: Rob Walker and Hannah Giles on how to manage patients when chronic kidney disease, hyperuricaemia, and gout coexist. Register here Metabolic Soup WEBINAR 16 June: Ryan Paul gives practical, evidence-based strategies for managing diabetes, dyslipidaemia, hypertension, gout, and kidney disease, with an emphasis on simplifying and integrating care across these in

From 1 July 2026, Pharmac will take over responsibility for funding medicines used in ambulances. This decision outlines changes to the Pharmaceutical Schedule to support this change in responsibility. Under this decision, we will also fund tenecteplase for use within emergency ambulance services and Primary Responses in Medical Emergencies (PRIME) services. We want to make sure that everyone who needs to know about this decision is aware of it. Please share this informatio

Pharmac is seeking feedback on a proposal to change the funded brand of dapsone tablets, which are currently supplied by Link Pharmaceuticals (Dapsone). We are also seeking feedback on a related change to remove the 25 mg tablet from the Pharmaceutical Schedule due to its discontinuation and replace it with a 50 mg (scored / halveable) tablet. A 100 mg tablet will remain available, but its brand would change. Proposal for the supply of dapsone tablets No changes are proposed

New medicine supply notices Reandron testosterone is changing brand to Gonadron Gonadron will be listed from 1 July. Reandron will remain funded until 1 December. Information (including pictures) is available on the website for affected people. Valaciclovir (Vaclovir) 1,000 mg (Pharmacode: 2483912) Stock of this product will run out. Two s29 alternatives have been listed. Please use the funded alternatives rather than 2 x 500 mg to avoid a supply issue affecting the lower

Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 05 June 2026. It includes information on: New updates Resolved Supply Issues Supply disruption: Colestyramine Powder for Oral Suspension (Sachet) There is a supply disruption affecting the currently listed colestyramine oral sachets, Colestyramine – Mylan S29. From 1 June, Pharmac listed (funded) an alternative Section 29 product: Questran Light (n

Based at Hāwera Hospital Permanent, full-time or part-time role Play a pivotal role in rural health Health New Zealand | Te Whatu Ora is firmly grounded in the principles of Te Tiriti o Waitangi and is committed to building a health system that serves all New Zealanders. About the role Mātanga tapuhi (Nurse Practitioners) and Nurse Practitioner Interns have advanced education, clinical training, and the demonstrated competence and legal authority to practise beyond the level

Nurse Practitioner – North Shore, Auckland No weekends | Flexible hours | Supportive team Join a well‑established general practice on Auckland’s North Shore. Work in a friendly, collaborative environment with excellent work–life balance. The Role Provide patient-centred care across acute, chronic, and preventive health needs in a supportive primary care setting. What We Offer No weekends or public holidaysFlexible hours. Established patient baseSupportive clinical and admin t

Colestyramine (Mylan) (Pharmacode: 2662000) Supplies may be limited from late May until July 2026. An alternative (Pharmacode: 2700026) was funded from 1 June and should be available from Orspec in early June. Kisqali (ribociclib): Storage changes Kisqali will once again be able to be stored at room temperature. More details and a flyer for patients are available on our website. Neocate Gold: Funding issue The Pharmacode for new look Neocate Gold was funded from 1 June. Oestr

Welcome to the latest update from the Ministry of Health | Manatū Hauora on the regulation of medicines, medical devices and natural health products. This edition provides information on the Government’s recent decision to regulate sunscreens and other policy matters under the Medical Products Bill (the Bill). This update also accompanies the proactive release of documents relating to those decisions. This newsletter contains information on the following: New policy decisions

There is currently a supply disruption affecting risperidone (Teva) 0.5 mg and 2 mg tablets. This is due to an issue at the manufacturer. To support continuity of care, from 1 June, Pharmac will list (fund) alternative products, Risperidone Sandoz 0.5 mg tab and Risperidone Sandoz 2 mg tab. Please note Risperidone Sandoz tablets are not Medsafe‑approved and must therefore be prescribed and supplied in accordance with Section 29A of the Medicines Act. Further information